Mitoxantrone: an active, new antitumor agent with an improved therapeutic index.
Saletan
S
S
Medical Research Division, Lederle Laboratories, American Cynamid Company, Pearl River, New York 10965.
D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D008942:Mitoxantrone / Q000009:adverse effects / Q000627:therapeutic use*
D004317:Doxorubicin; D008942:Mitoxantrone